Quelles sont les heures d'ouverture ?

Lundi 09:00 - 18:00 Mardi 09:00 - 18:00 Mercredi 09:00 - 18:00 Jeudi 09:00 - 18:00 Vendredi 09:00 - 17:00

Lumibird Medical

Lighting the Way in Patient Care

LIGHTING THE WAY IN PATIENT CARE

Lumibird Medical, a division of the Lumibird Group specialised in laser technologies, offers healthcare professionals around the world a wide range of diagnosis and treatment solutions through 3 medical equipment brands: Quantel Medical, Ellex, and Optotek Medical. In ophthalmology, our innovative, patient-centred laser and ultrasound solutions are designed hand-i

n-hand with healthcare professionals to help more people fight the 4 major causes of blindness (cataract, glaucoma, diabetic retinopathy and macular degeneration) as well as other pathologies such as dry eye.

13/08/2026

𝗢𝗻𝗹𝘆 𝟰𝟰% 𝗼𝗳 𝗽𝗲𝗼𝗽𝗹𝗲 𝘄𝗵𝗼 𝗻𝗲𝗲𝗱 𝗰𝗮𝘁𝗮𝗿𝗮𝗰𝘁 𝘀𝘂𝗿𝗴𝗲𝗿𝘆 𝘄𝗼𝗿𝗹𝗱𝘄𝗶𝗱𝗲 𝗿𝗲𝗰𝗲𝗶𝘃𝗲 𝗲𝗳𝗳𝗲𝗰𝘁𝗶𝘃𝗲 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁.

Cataract remains one of the leading causes of vision impairment, even though it is one of the most treatable eye conditions.

Improving access to high-quality cataract surgery is essential to reducing avoidable vision loss and helping millions of people regain their independence and quality of life.

At Lumibird Medical, we are committed to advancing ophthalmic technologies that support eye care professionals in delivering safe, effective and high-quality patient care.

𝑆𝑜𝑢𝑟𝑐𝑒: 𝐼𝐴𝑃𝐵 𝑉𝑖𝑠𝑖𝑜𝑛 𝐴𝑡𝑙𝑎𝑠 (2025) – 𝐺𝑙𝑜𝑏𝑎𝑙 𝐷𝑎𝑡𝑎

10/08/2026

We're excited to announce that Lumibird Medical Asia Pacific will be attending the APVRS Congress 2026, taking place August 28–30 in Australia.

Join our team to discover how our innovative ophthalmic laser solutions are helping eye care professionals deliver precision, efficiency, and outstanding patient care.

📍 Visit us during the congress to meet our experts, explore our latest technologies, and discuss how we can support your clinical practice.

We look forward to connecting with ophthalmologists, partners, and industry professionals from across the Asia-Pacific region.

07/08/2026

💎 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗣𝗲𝗮𝗿𝗹 #𝟮

B-Scan Ultrasound Is Dynamic, Not Static

One of the most common misconceptions about B-scan ultrasonography is thinking of it as a simple image capture.

It’s a dynamic examination.

During the examination, both the probe and the patient’s gaze should be actively moved.

This dynamic exploration of the globe allows clinicians to assess different anatomical structures, improve lesion characterization, and identify findings that may not be visible on a single static image.

✅ Clinical takeaway: Small movements can make a big difference when evaluating the posterior segment.

📖 Learn more from Prof. Mario De La Torre: https://ophthalmology.lumibirdmedical.com/blogposts/mastering-the-technics-for-posterior-pole-b-mode-examination-en?specialisation=multi

What are your favorite tips for optimizing posterior segment B-scan examinations?

05/08/2026

🟠 𝗦𝗧𝗔𝗡𝗗𝗔𝗥𝗗𝗜𝗭𝗘𝗗 𝗨𝗟𝗧𝗥𝗔𝗦𝗢𝗨𝗡𝗗 𝗖𝗢𝗨𝗥𝗦𝗘 - 𝗣𝗘𝗥𝗨 🇵🇪
Lumibird Medical was pleased to present the 7th standardized ultrasound course, held in Lima from July 17 to 19.

During the course, participants had the opportunity to take part in both theoretical and hands-on sessions and explore our complete ultrasound portfolio, including 𝗔𝗕𝗦𝗼𝗹𝘂, our premium platform for standardized ultrasound.

A sincere thank you to all attendees for their active participation, and to Prof. Mario de La Torre, Gabriela Quezada, MD, and Malena Tomihama, MD for sharing their expertise and contributing to the success of this course.

For further information or to discover our ultrasound range: https://ophthalmology.lumibirdmedical.com/products/Ultrasound

03/08/2026

𝟵𝟬% 𝗼𝗳 𝘀𝗶𝗴𝗵𝘁 𝗹𝗼𝘀𝘀 𝗶𝘀 𝗽𝗿𝗲𝘃𝗲𝗻𝘁𝗮𝗯𝗹𝗲 𝗼𝗿 𝘁𝗿𝗲𝗮𝘁𝗮𝗯𝗹𝗲.

This powerful figure reminds us that millions of people could preserve or regain their vision through timely diagnosis, access to appropriate care and effective treatment.

Advancing eye health requires continued innovation, collaboration and a shared commitment to making quality care more accessible around the world.

At Lumibird Medical, we are proud to support eye care professionals with technologies designed to help improve patient outcomes and contribute to better vision for more people.

𝑆𝑜𝑢𝑟𝑐𝑒: 𝐼𝐴𝑃𝐵 𝑉𝑖𝑠𝑖𝑜𝑛 𝐴𝑡𝑙𝑎𝑠 (2025) – 𝐺𝑙𝑜𝑏𝑎𝑙 𝐷𝑎𝑡𝑎

30/07/2026

As Dry Eye Awareness Month comes to a close, our commitment to patient education continues.

𝘄𝘄𝘄.𝗺𝘆𝗱𝗿𝘆𝗲𝘆𝗲𝗱𝗶𝘀𝗲𝗮𝘀𝗲.𝗰𝗼𝗺 now reflects the latest TFOS DEWS III recommendations, providing patients with clear, evidence-based information on the recommended diagnostic approach for the three key areas involved in dry eye disease: tear film, eyelids (MGD) and ocular surface.

Patients can also complete the OSDI-6 questionnaire, recommended by TFOS DEWS III to assess the impact of dry eye symptoms before consulting an eye care professional.

By helping patients better understand dry eye disease and its management, we aim to promote greater engagement and better acceptance of the care pathway.

➡️ Explore http://MyDryEyeDisease.com

27/07/2026

Dry eye disease is still largely under-recognised and often misunderstood by patients.

Yet patient understanding is essential for successful long-term management.

At Lumibird Medical, we believe patient education is not an extra step. It is an integral part of dry eye care.

That's why we have developed a complete ecosystem of educational resources designed to help eye care professionals inform, engage and support their patients throughout their journey.

From printed materials available in the waiting room to digital resources, educational videos and dedicated online content, our goal is simple: help patients better understand their condition so they can actively participate in their care.

Through http://MyDryEyeDisease.com , patients can access reliable information about dry eye disease, its causes, symptoms and treatment options, while healthcare professionals can increase their visibility and help patients find dedicated dry eye care.

Because informed patients are more engaged patients. And engaged patients lead to better long-term outcomes.

Discover C.SUITE:
https://ophthalmology.lumibirdmedical.com/landing-page/c-suite-complete-offer-dedicated-to-dry-eye-en

23/07/2026

💎 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗣𝗲𝗮𝗿𝗹 #𝟭

With subthreshold retinal laser, the absence of a visible retinal burn doesn't mean the treatment isn't working.

Unlike conventional laser photocoagulation, subthreshold laser aims to stimulate the retinal pigment epithelium while preserving retinal tissue. The goal is to trigger a biological response—not to create visible retinal damage.

Clinical takeaway: Modern retinal laser strategies focus on tissue preservation while supporting the retina's natural repair mechanisms.

📖 Discover more insights from Dr. Marco Lupidi:https://ophthalmology.lumibirdmedical.com/uploads/images/media_library_pdf/an-dr-lupidi-retinatoday-2026-6a15885e3adfb985678810.pdf

20/07/2026

Dry eye disease management is not about one technology or one treatment alone.

Successful management combines patient education, daily care routines, long-term follow-up and dedicated treatment options tailored to each patient's needs.

Among these treatment pillars, C.STIM® IPL provides eye care professionals with a targeted solution designed to support the management of meibomian gland dysfunction, one of the leading causes of dry eye disease.

With dedicated C.TIPS®, treatment can be adapted to different anatomical areas while maintaining a seamless workflow and precise delivery.

Because comprehensive dry eye care requires both a global vision and the right tools at the right time.

Discover C.SUITE:
https://ophthalmology.lumibirdmedical.com/landing-page/c-suite-complete-offer-dedicated-to-dry-eye-en

17/07/2026

🎙 𝗟𝘂𝗺𝗶𝗯𝗶𝗿𝗱 𝗲𝗻𝘁𝗲𝗿𝘀 𝗶𝗻𝘁𝗼 𝗲𝘅𝗰𝗹𝘂𝘀𝗶𝘃𝗲 𝗻𝗲𝗴𝗼𝘁𝗶𝗮𝘁𝗶𝗼𝗻𝘀 𝗳𝗼𝗿 𝘁𝗵𝗲 𝘀𝗮𝗹𝗲 𝗼𝗳 𝗶𝘁𝘀 𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗱𝗶𝘃𝗶𝘀𝗶𝗼𝗻 𝘁𝗼 𝗜𝗣𝗚 𝗣𝗵𝗼𝘁𝗼𝗻𝗶𝗰𝘀 𝗖𝗼𝗿𝗽𝗼𝗿𝗮𝘁𝗶𝗼𝗻

Following receipt of a binding offer, Lumibird Group announces today that it has entered into exclusive negotiations for the sale of its Medical Division to IPG Photonics Corporation, for an enterprise value of €300 million, which may be increased by an earn-out of up to €50 million based on future performance in 2026 and 2027.

More than a portfolio transaction, this proposed transaction would represent a defining milestone in Lumibird’s history.

The proposed transaction could be finalized during Q4 2026, following consultation with the relevant employee representative bodies and the satisfaction of customary closing conditions.

Lumibird Medical is delighted by the news. Business continues as usual, and our priority remains unchanged: delivering outstanding service to our customers and distributors.

👉 Full press release: https://www.lumibirdmedical.com/sale-of-medical-divison-to-ipg-photonics-corporation/

Adresse

1 Rue Du Bois Joli
Cournon-d'Auvergne
63800

Heures d'ouverture

Lundi	09:00 - 18:00
Mardi	09:00 - 18:00
Mercredi	09:00 - 18:00
Jeudi	09:00 - 18:00
Vendredi	09:00 - 17:00

Site Web

https://www.lumibirdmedical.com/

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque Lumibird Medical publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.